Edgewise Therapeutics
Sara Cantrell has a diverse work experience spanning different industries. sara is currently a Senior Research Associate at Edgewise Therapeutics, starting in October 2022. Prior to that, they worked as a Research Associate at Unnatural Products Inc. from April 2021 to September 2022. sara also served as an Associate Researcher at Santa Cruz Biotechnology (SCBT) from September 2020 to April 2021. In addition, Sara worked as an Emergency Medical Scribe at Vituity in Dominican Hospital from December 2018 to April 2021. sara began their career as a Laboratory Assistant at the University of California, Santa Cruz from August 2018 to January 2019.
Sara Cantrell's education history includes attending the University of California, Santa Cruz from 2016 to 2020. There, they pursued a degree in Molecular Biology, with a specialization in Cell/Cellular and Molecular Biology.
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.